Study of Fenretinide in the Treatment of Geographic Atrophy Associated With Dry Age-Related Macular Degeneration
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this phase II study is to determine the efficacy of fenretinide in the
treatment of geographic atrophy (GA) in subjects with the dry form of age-related macular
degeneration (AMD).